Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004;2004(1):CD003955.
doi: 10.1002/14651858.CD003955.pub2.

Naloxone for preventing morbidity and mortality in newborn infants of greater than 34 weeks' gestation with suspected perinatal asphyxia

W McGuire  1 , P W Fowlie, D J Evans
Affiliations

Naloxone for preventing morbidity and mortality in newborn infants of greater than 34 weeks' gestation with suspected perinatal asphyxia

W McGuire et al. Cochrane Database Syst Rev. 2004.

Abstract

Background: Studies in animal models have suggested that naloxone, a specific opiate antagonist, may improve outcomes for newborn infants with perinatal asphyxia.

Objectives: In newborn infants of greater than 34 weeks' gestation with suspected perinatal asphyxia: to assess the effects of naloxone versus placebo or no drug, and of single versus multiple doses of naloxone, on mortality, long term neurological problems, severity of hypoxic-ischaemic encephalopathy, and frequency of neonatal seizures.

Search strategy: We used the standard search strategy of the Cochrane Neonatal Review Group. This included searches of the Cochrane Central Register of Controlled Trials (CENTRAL, The Cochrane Library, Issue 3, 2003), MEDLINE (1966 - August 2003), EMBASE (1980 - August 2003), conference proceedings, and previous reviews.

Selection criteria: Randomised or quasi-randomised controlled trials comparing naloxone versus placebo, or no drug, or another dose of naloxone, in newborn infants of greater than 34 weeks' gestation with suspected perinatal asphyxia.

Data collection and analysis: We extracted data using the standard methods of the Cochrane Neonatal Review Group, with separate evaluation of trial quality and data extraction by two authors. The pre-specified outcomes for this review were: death before hospital discharge, severe neurodevelopmental disability, severity of hypoxic-ischaemic encephalopathy, and seizures in the neonatal period.

Main results: We identified only one eligible randomised controlled trial. This study compared the use of naloxone with placebo in newborn infants with an Apgar score of six or less at one minute after birth. There were not any data on the pre-specified outcomes for this review.

Reviewer's conclusions: There are insufficient data available to evaluate the safety and effectiveness of the routine use of naloxone for newborn infants of greater than 34 weeks' gestation with suspected perinatal asphyxia. A further randomised controlled trial is needed to determine if naloxone benefits newborn infants with suspected perinatal asphyxia. Such a trial should assess clinically important outcomes such as mortality, and adverse short and long term neurological outcomes.

PubMed Disclaimer

Conflict of interest statement

None

Update of

References

References to studies included in this review

Chernick 1988 {published data only}
    1. Chernick V, Manfreda J, Booy V, Davi M, Rigatto H, Seshia M. Clinical trial of naloxone in birth asphyxia. Journal of Pediatrics 1988;113:519‐25. - PubMed

References to studies excluded from this review

Zhang 1996 {published data only}
    1. Zhang SD, Qian PD, Zhang SQ, Jin LJ, Liang QJ. Effect of naloxone in treatment of neonatal hypoxic‐ischemic encephalopathy. Chinese Medical Journal 1996;11:207‐9.

Additional references

AAP 1980
    1. American Academy of Pediatrics Committee on Drugs. Naloxone use in newborns. Pediatrics 1980;65:667‐9. - PubMed
AAP 1990
    1. American Academy of Pediatrics Committee on Drugs. Naloxone dosage and route of administration for infants and children: addendum to emergency drug doses for infants and children. Pediatrics 1990;86:484‐5. - PubMed
Airede 1991
    1. Airede AI. Birth asphyxia and hypoxic‐ischaemic encephalopathy: incidence and severity. Annals of Tropical Paediatrics 1991;11:331‐5. - PubMed
Catlin 1986
    1. Catlin EA, Carpenter MW, Brann BS 4th, Mayfield SR, Shaul PW, Goldstein M, Oh W. The Apgar score revisited: influence of gestational age. Journal of Pediatrics 1986;109:865‐8. - PubMed
Chernick 1980
    1. Chernick V, Madansky DL, Lawson EE. Naloxone decreases the duration of primary apnea with neonatal asphyxia. Pediatric Research 1980;14:357‐9. - PubMed
Chernick 1982
    1. Chernick V, Craig RJ. Naloxone reverses neonatal depression caused by fetal asphyxia. Science 1982;216:1252‐3. - PubMed
Evans 2001
    1. Evans DJ, Levene MI. Anticonvulsants for preventing mortality and morbidity in full term newborns with perinatal asphyxia. Cochrane Database of Systematic Reviews 2001, Issue 2. [DOI: 10.1002/14651858.CD001240.pub2] - DOI - PubMed
Herschel 2000
    1. Herschel M, Khoshnood B, Lass NA. Role of naloxone in newborn resuscitation. Pediatrics 2000;106:831‐4. - PubMed
Hunt 2002
    1. Hunt R, Osborn D. Dopamine for prevention of morbidity and mortality in term newborn infants with suspected perinatal asphyxia. Cochrane Database of Systematic Reviews 2002, Issue 3. [DOI: 10.1002/14651858.CD003484] - DOI - PMC - PubMed
Jacobs 2003
    1. Jacobs S, Hunt R, Tarnow‐Mordi W, Inder T, Davis P. Cooling for newborns with hypoxic ischaemic encephalopathy. Cochrane Database of Systematic Reviews 2003, Issue 4. [DOI: 10.1002/14651858.CD003311.pub2] - DOI - PubMed
Kecskes 2005
    1. Kecskes Z, Healy G, Jensen A. Fluid restriction for term infants with hypoxic‐ischaemic encephalopathy following perinatal asphyxia. Cochrane Database of Systematic Reviews 2005, Issue 3. [DOI: 10.1002/14651858.CD004337.pub2] - DOI - PMC - PubMed
Levene 1985
    1. Levene MI, Kornberg J, Williams TH. The incidence and severity of post‐asphyxial encephalopathy in full‐term infants. Early Human Development 1985;11:21‐6. - PubMed
Lou 1989
    1. Lou HC, Tweed WA, Davis JM. Endogenous opioids may protect the perinatal brain in hypoxia. Developments in Pharmacological Therapies 1989;13:129‐33. - PubMed
MacLennan 1999
    1. MacLennan A. A template for defining a causal relation between acute intrapartum events and cerebral palsy: international consensus statement. BMJ 1999;319:1054‐9. - PMC - PubMed
McGuire 2007
    1. McGuire W, Fowlie P. Naloxone for narcotic exposed newborn infants. Cochrane Database of Systematic Reviews 2007, Issue 3. [DOI: 10.1002/14651858.CD003483] - DOI - PubMed
NRP 2000
    1. Neonatal Resuscitation Program. Textbook of Neonatal Resuscitation. 4th Edition. American Academy of Pediatrics, American Heart Association, Heart and Stroke Foundation of Canada, 2000.
Oswyn 2000
    1. Oswyn G, Vince JD, Friesen H. Perinatal asphyxia at Port Moresby General Hospital: a study of incidence, risk factors and outcome. Papua and New Guinea Medical Journal 2000;43:110‐20. - PubMed
Padbury 1987
    1. Padbury JF, Agata Y, Polk DH, Wang DL, Callegari CC. Neonatal adaptation: naloxone increases the catecholamine surge at birth. Pediatric Research 1987;21:590‐3. - PubMed
Sarnat 1976
    1. Sarnat HB, Sarnat MS. Neonatal encephalopathy following fetal distress. A clinical and electroencephalographic study. Archives of Neurology 1976;33:696‐705. - PubMed
Singh 1991
    1. Singh M, Deorari AK, Khajuria RC, Paul VK. A four year study on neonatal morbidity in a New Delhi hospital. Indian Journal of Medical Research 1991;94:186‐92. - PubMed
Thornberg 1995
    1. Thornberg E, Thiringer K, Odeback A, Milsom I. Birth asphyxia: incidence, clinical course and outcome in a Swedish population. Acta Paediatrica 1995;84:927‐32. - PubMed
Ting 1994
    1. Ting P, Pan Y. The effects of naloxone on the post‐asphyxic cerebral pathophysiology of newborn lambs. Neurological Research 1994;16:359‐64. - PubMed
Young 1984
    1. Young RS, Hessert TR, Pritchard GA, Yagel SK. Naloxone exacerbates hypoxic‐ischemic brain injury in the neonatal rat. American Journal of Obstetetrics and Gynecology 1984;150:52‐6. - PubMed

References to other published versions of this review

McGuire 2004
    1. McGuire W, Fowlie PW, Evans DJ. Naloxone for preventing morbidity and mortality in newborn infants of greater than 34 weeks' gestation with suspected perinatal asphyxia. Cochrane Database of Systematic Reviews 2004, Issue 1. [DOI: 10.1002/14651858.CD003955.pub2] - DOI - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources